Wag Group Co (PET) concluded trading on Wednesday at a closing price of $0.11, with 19.25 million shares of worth about $2.12 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -86.57% during that period and on April 23, 2025 the price saw a gain of about 17.59%. Currently the company’s common shares owned by public are about 50.26M shares, out of which, 24.64M shares are available for trading.
Stock saw a price change of -10.33% in past 5 days and over the past one month there was a price change of -43.72%. Year-to-date (YTD), PET shares are showing a performance of -53.71% which decreased to -94.77% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.08 but also hit the highest price of $2.47 during that period. The average intraday trading volume for Wag Group Co shares is 564.22K. The stock is currently trading -16.78% below its 20-day simple moving average (SMA20), while that difference is down -48.50% for SMA50 and it goes to -80.06% lower than SMA200.
Wag Group Co (NASDAQ: PET) currently have 50.26M outstanding shares and institutions hold larger chunk of about 10.96% of that.
The stock has a current market capitalization of $5.60M and its 3Y-monthly beta is at 1.19. It has posted earnings per share of -$0.39 in the same period. It has Quick Ratio of 0.51. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PET, volatility over the week remained 22.52% while standing at 20.56% over the month.
Analysts are in expectations that Wag Group Co (PET) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.
Coverage by Lake Street stated Wag Group Co (PET) stock as a Buy in their note to investors on May 30, 2024, suggesting a price target of $4 for the stock. On November 22, 2022, Oppenheimer Initiated their recommendations, while on October 17, 2022, ROTH Capital Initiated their ratings for the stock with a price target of $5. Stock get a Buy rating from Craig Hallum on October 14, 2022.
